| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 05/03/2000 | EP0997145A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
| 05/03/2000 | EP0996857A2 Cancer associated nucleic acids and polypeptides |
| 05/03/2000 | EP0996733A1 Phosphatidylinositol 4,5-bisphosphate 5-phosphatase from human |
| 05/03/2000 | EP0996726A1 T-cell membrane protein (tirc7), peptides and antibodies derived therefrom and uses thereof |
| 05/03/2000 | EP0996725A1 Human nk-3 related prostate specific gene-1 |
| 05/03/2000 | EP0996723A1 Human phosphatidylinositol transfer protein gamma |
| 05/03/2000 | EP0996638A2 Methods and compositions for treating abnormal cell growth related to unwanted guanine nucleotide exchange factor activity |
| 05/03/2000 | EP0996635A1 Novel family of pheromone receptors |
| 05/03/2000 | EP0996630A2 Irs-p53h, human insulin receptor tyrosine kinase substrate |
| 05/03/2000 | EP0996467A1 Txu-7-pap immunotoxin and use thereof |
| 05/03/2000 | EP0996466A2 Novel composition comprising an ssri and a beta-blocker |
| 05/03/2000 | EP0996460A1 TREATMENT OF ACUTE LUNG INJURY AND FIBROSIS WITH ANTAGONISTS OF $g(a)v$g(b)6 |
| 05/03/2000 | EP0996459A1 Use of exendins and agonists thereof for the reduction of food intake |
| 05/03/2000 | EP0996456A1 Methods for treating neurological deficits |
| 05/03/2000 | EP0996455A1 $g(a)-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF |
| 05/03/2000 | EP0996447A1 Combination therapy for modulating the human sexual response |
| 05/03/2000 | EP0996445A1 Treatment and prevention of cardiac disorders using selective serotonin re-uptake inhibitors (ssri) |
| 05/03/2000 | EP0996444A1 Treatment of diabetes with thiazolidinedione and metformin |
| 05/03/2000 | EP0996441A1 Pharmaceutical compositions of arglabin and arglabin derivatives |
| 05/03/2000 | EP0996436A1 Pharmaceutical formulations containing poorly soluble drug substances |
| 05/03/2000 | EP0996433A1 Methods for treatment of conditions associated with lactosylceramide |
| 05/03/2000 | EP0996429A1 Solid state solutions and dispersions of poorly water soluble drugs |
| 05/03/2000 | EP0996428A2 Topical application of a combination of benzoyl peroxide and a second active ingredient |
| 05/03/2000 | EP0776334A4 Stable analogs of bioactive peptides containing disulfide linkages |
| 05/03/2000 | EP0652768B1 A pharmaceutical preparation for the synergistic activation of natural killer cells |
| 05/03/2000 | EP0625055B1 Use of fullerenes in diagnostic and/or therapeutic agents |
| 05/03/2000 | CN1252000A Pharmaceutical compositions having appetite suppressant activity |
| 05/03/2000 | CN1251996A Combination therapy for HIV infections |
| 05/03/2000 | CN1251993A Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections |
| 05/03/2000 | CN1251989A Methods and compositions for preventing and treating chronological aging in human skin |
| 05/03/2000 | CN1051922C Formulation comprising antibacterial substance and anticancer substance |
| 05/03/2000 | CN1051919C Depigmenting composition for the simultaneous treatment of surface layers and deep layers of skin, and use thereof |
| 05/02/2000 | US6057435 Nucleic acid coding for polypeptide which binds to receptor tyrosine kinase containing immunoglobulin-like and epidermal growth factor homology domains expressed in vascular endothelial cells; diagnosis/imaging; angiogenesis inhibition |
| 05/02/2000 | US6057432 CysS |
| 05/02/2000 | US6057361 Formulations and methods of reducing toxicity of antineoplastic agents |
| 05/02/2000 | US6057347 Comprising nonsteroidal antiinflammatory drug and compound that donates, transfers, or releases nitric oxide, elevates endogenous synthesis levels of nitric oxide, or is substrate for nitric oxide synthase |
| 05/02/2000 | US6057323 Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 05/02/2000 | US6057122 Antiangiogenic peptides polynucleotides encoding same and methods for inhibiting angiogenesis |
| 05/02/2000 | US6057112 Ubiquitin conjugation proteins |
| 05/02/2000 | US6057093 Genetically engineering nucleotide sequences for efficient protein synthesis of viral genes; linking a conserved nucleotide sequence to the terminal end of a ribonucleic acid sequence and activating protein synthesis |
| 05/02/2000 | US6056959 CD40 antigen antibody complex |
| 05/02/2000 | US6056944 Pharmaceutical compositions for oral use including an NSAID and ceramides |
| 05/02/2000 | US6056715 Surgical irrigation solution and method for inhibition of pain and inflammation |
| 04/27/2000 | WO2000023618A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | WO2000023600A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | WO2000023599A2 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | WO2000023575A1 Ups (ugc) |
| 04/27/2000 | WO2000023466A2 Human rna binding proteins |
| 04/27/2000 | WO2000023438A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | WO2000023115A1 TREATMENT OF TRAUMA (I.E. GRAFT REJECTION) WITH LIPOSOMES CONTAINING DNA ENCODING FOR CTLA4Ig OR FOR ANTI-CD40L |
| 04/27/2000 | WO2000023112A1 Modulation of gene expression by combination therapy |
| 04/27/2000 | WO2000023102A1 Method for regulating the permeability of the blood brain barrier |
| 04/27/2000 | WO2000023100A2 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | WO2000023097A1 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
| 04/27/2000 | WO2000023096A2 Combination therapy with vip antagonist |
| 04/27/2000 | WO2000023091A2 Specific therapeutic interventions obtained by interference with redistribution and/or targeting of cyclic nucleotide phosphodiesterases of i-kappa-b kinases |
| 04/27/2000 | WO2000023086A2 Buffered compositions for dialysis |
| 04/27/2000 | WO2000023074A1 Pharmaceutical composition containing decursin |
| 04/27/2000 | WO2000023072A1 Irrigation solution containing mapk inhibitors and their use for treating pain and inflammation |
| 04/27/2000 | WO2000023066A2 Irrigation solution and method for inhibition of pain and inflammation |
| 04/27/2000 | WO2000023065A2 Storable active substance concentrate with formoterol |
| 04/27/2000 | WO2000023064A1 Treatment of dyspepsia |
| 04/27/2000 | WO2000023062A2 Irrigation solution and method for inhibition of pain and inflammation |
| 04/27/2000 | WO2000023060A2 Method of treating immunological disorders mediated by t-lymphocytes |
| 04/27/2000 | WO2000023057A2 Atypical antiphsychotic in combination with acetylcholinesterase inhibitor for improving cognition |
| 04/27/2000 | WO2000023052A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | WO2000023051A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | WO2000023037A1 Two chamber cartridge for atomizers |
| 04/27/2000 | WO2000023023A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | WO2000007014A3 Leptin-mediated gene-induction |
| 04/27/2000 | WO2000005407A3 DUPLICATIONS OF HUMAN CHROMOSOME 15q24-25 AND ANXIETY DISORDERS, DIAGNOSTIC METHODS FOR THEIR DETECTION |
| 04/27/2000 | WO2000004888A3 Use of cyclodextrins for the treatment of cerebral ischaemia and central nervous system injury |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | WO1999062459A9 Agents and methods for protection, treatment and repair of connective tissue |
| 04/27/2000 | WO1999061085A9 Method and compositions for treatment of cancers |
| 04/27/2000 | WO1999061010A3 Treatment of infertility with cam-increasing compounds alone or in combination with at least one meiosis-stimulating compound |
| 04/27/2000 | WO1999051220A9 Methods and compositions for reducing uv-induced inhibition of collagen synthesis in human skin |
| 04/27/2000 | DE19849073A1 Transgene encoding amyloid precursor protein or its fragment, used to produce transgenic nematodes used, e.g. to screen for agents for treating Alzheimer's disease |
| 04/27/2000 | DE19848856A1 Topically applied film-forming composition containing antiandrogenic N-phenyl-azolidine compound, used for treating hirsutism, seborrhea, acne or especially androgenetic alopecia |
| 04/27/2000 | DE19842863A1 Regulatorisches Protein aus humanen Keratinozyten Regulatory protein from human keratinocytes |
| 04/27/2000 | CA2348156A1 Human proteins involved in endoplasmic reticulum protein degradation |
| 04/27/2000 | CA2347654A1 Human rna binding proteins |
| 04/27/2000 | CA2347625A1 Genes and proteins predictive and therapeutic for renal disease and associated disorders |
| 04/27/2000 | CA2347108A1 Aerosol ointment compositions and method of manufacture |
| 04/27/2000 | CA2347003A1 Modulation of gene expression by combination therapy |
| 04/27/2000 | CA2346937A1 Specific therapeutic interventions obtained by interference with redistribution and/or targeting |
| 04/27/2000 | CA2346879A1 Liposome-entrapped topoisomerase inhibitors |
| 04/27/2000 | CA2346866A1 Combination therapy with vip antagonist |
| 04/27/2000 | CA2346656A1 Methods of hydrating mucosal surfaces |
| 04/27/2000 | CA2346436A1 N-(imidazolylalkyl)substituted cyclic amines as histamine-h3 agonists or antagonists |
| 04/27/2000 | CA2345938A1 Polymorphism in a tgf-beta gene correlated to osteoporosis |
| 04/27/2000 | CA2345767A1 Therapy for improving cognition |
| 04/27/2000 | CA2343974A1 Materials and methods involving conditional aggregation domains |
| 04/27/2000 | CA2342794A1 Use of growth hormone or analogues thereof for the treatment of mammals with familial hypercholesterolemia |
| 04/26/2000 | EP0995798A1 Transcription factor of MHC class II genes, substances capable of inhibiting this new transcription factor and medical uses of these substances |
| 04/26/2000 | EP0995447A1 Formulation comprising antibacterial substance and antiulcer substance |
| 04/26/2000 | EP0995441A2 Combination of compounds for treating erectile dysfunctions |
| 04/26/2000 | EP0995439A1 Use of indazole derivatives in the manufacture of a medicament for treating congestive heart failure |
| 04/26/2000 | EP0995120A1 Protein elongation factor 2 as a target for antifungal and antiparasitic agents |
| 04/26/2000 | EP0994966A1 Member of the tnf family useful for treatment and diagnosis of disease |